← 產業報告目錄

Medical Isotope Production Market Size, Share & Trends Analysis Report by Scale of Operation (Commercial Scale and Preclinical / Clinical Scale), Type of Isotope (Radioisotope (Technetium-99m, Fluorine-18, Leutetium-177, Actinium-225 and Other Radioisotopes) and Stable Isotopes), Production Method, Application Area, Type of Diagnostic Radioisotope, Type of Therapeutic Radioisotope, Therapeutic Area, End Users, by Region, And by Segment Forecasts, 2025-2034

出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-29頁數 180報告編號 INSIGHTACE-f7bdf314f4

授權報價

Single User PDF$4,500 USD
Global Site License PDF$9,500 USD
洽詢購買 申請 Sample

報告摘要

In 2024, the Medical Isotope Production Market worldwide was assessed at USD 4.2 Bn. Analysts project it will increase to USD 8.4 Bn by 2034, at a CAGR of 7.3% spanning 2025 to 2034. Medical Isotope Production covers radioactive atoms used in medical diagnostics and treatments. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space. Market momentum is bolstered by escalating call for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies. The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion. From a regional perspective, mature markets in North America and Europe continue to hold substantial shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and escalating investment in the sector. Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players. This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Medical Isotope Production Market Snapshot Chapter 4. Global Medical Isotope Production Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Porter's Five Forces Analysis 4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031 4.8. Global Medical Isotope Production Market Penetration & Growth Prospect Mapping (US$ Mn), 2025-2034 4.9. Competitive Landscape & Market Share Analysis, By Key Player (2024 4.10. Use/impact of AI on Radiopharma Industry Trends Chapter 5. Medical Isotope Production Market Segmentation 1: By Scale of Operation, Estimates & Trend Analysis 5.1. Market Share by Scale of Operation, 2024 & 2034 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following Scale of Operation: 5.2.1. Commercial Scale 5.2.2. Preclinical / Clinical Scale Chapter 6. Medical Isotope Production Market Segmentation 2: By Type of Isotope, Estimates & Trend Analysis 6.1. Market Share by Type of Isotope, 2024 & 2034 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following Type of Isotope: 6.2.1. Radioisotopes 6.2.1.1. Technetium-99m 6.2.1.2. Leutetium-177 6.2.1.3. Fluorine-18 6.2.1.4. Actinium-225 6.2.1.5. Others 6.2.2. Stable Isotopes Chapter 7. Medical Isotope Production Market Segmentation 3: By Production Method, Estimates & Trend Analysis 7.1. Market Share by Production Method, 2024 & 2034 7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following Production Method: 7.2.1. Nuclear Reactors 7.2.2. Accelerators 7.2.3. Other Methods Chapter 8. Medical Isotope Production Market Segmentation 4: By Application Area, Estimates & Trend Analysis 8.1. Market Share by Application Area, 2024 & 2034 8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following Application Area: 8.2.1. Diagnosis 8.2.2. Nuclear Therapy 8.2.3. Other Applications Chapter 9. Medical Isotope Production Market Segmentation 5: By Type of Diagnostic Radioisotope, Estimates & Trend Analysis 9.1. Market Share by Type of Diagnostic Radioisotope, 2024 & 2034 9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following Type of Diagnostic Radioisotope: 9.2.1. SPECT Radioisotopes 9.2.2. PET Radioisotopes Chapter 10. Medical Isotope Production Market Segmentation 6: By Type of Therapeutic Radioisotope, Estimates & Trend Analysis 10.1. Market Share by Type of Therapeutic Radioisotope, 2024 & 2034 10.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following Type of Therapeutic Radioisotope: 10.2.1. Beta Emitters 10.2.2. Alpha Emitters 10.2.3. Other Emitters Chapter 11. Medical Isotope Production Market Segmentation 7: By Therapeutic Area, Estimates & Trend Analysis 11.1. Market Share by Therapeutic Area, 2024 & 2034 11.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following Therapeutic Area: 11.2.1. Oncological Disorders 11.2.2. Cardiovascular Disorders 11.2.3. Neurological Disorders 11.2.4. Other Disorders Chapter 12. Medical Isotope Production Market Segmentation 8: By End Users, Estimates & Trend Analysis 12.1. Market Share by End Users, 2024 & 2034 12.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following End Users: 12.2.1. Hospitals 12.2.2. Diagnostic Centers 12.2.3. Research Institutes Chapter 13. Medical Isotope Production Market Segmentation 9: Regional Estimates & Trend Analysis 13.1. Global Medical Isotope Production Market, Regional Snapshot 2024 & 2034 13.2. North America 13.2.1. North America Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034 13.2.1.1. US 13.2.1.2. Canada 13.2.2. North America Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2021-2034 13.2.3. North America Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Type of Isotope, 2021-2034 13.2.4. North America Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Radioisotope 2021-2034 13.2.5. North America Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2021-2034 13.2.6. North America Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2021-2034 13.2.7. North America Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Type of Diagnostic Radioisotope, 2021-2034 13.2.8. North America Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Type of Therapeutic Radioisotope, 2021-2034 13.2.9. North America Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034 13.2.10. North America Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2021-2034 13.3. Europe 13.3.1. Europe Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034 13.3.1.1. Denmark 13.3.1.2. Finland 13.3.1.3. Austria 13.3.1.4. France 13.3.1.5. Germany 13.3.1.6. Israel 13.3.1.7. Italy 13.3.1.8. Netherlands 13.3.1.9. Norway 13.3.1.10. Poland 13.3.2. Europe Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2021-2034 13.3.3. Europe Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Type of Isotope, 2021-2034 13.3.4. Europe Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Radioisotope 2021-2034 13.3.5. Europe Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Production Method, 2021-2034 13.3.6. Europe Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2021-2034 13.3.7. Europe Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Type of Diagnostic Radioisotope, 2021-2034 13.3.8. Europe Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts Type of Therapeutic Radioisotope, 2021-2034 13.3.9. Europe Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034 13.3.10. Europe Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2021-2034 13.4. Asia Pacific 13.4.1. Asia Pacific Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034 13.4.1.1. Australia 13.4.1.2. China 13.4.1.3. India 13.4.1.4. Indonesia 13.4.1.5. Japan 13.4.1.6. Malaysia 13.4.1.7. Philippines 13.4.1.8. Singapore 13.4.1.9. South Korea 13.4.1.10. Taiwan 13.4.1.11. Thailand 13.4.1.12. Rest of APAC 13.4.2. Asia Pacific Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2021-2034 13.4.3. Asia Pacific Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Type of Isotope, 2021-2034 13.4.4. Asia Pacific Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts By Radioisotope 2021-2034 13.4.5. Asia Pacific Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Production Method, 2021-2034 13.4.6. Asia Pacific Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2021-2034 13.4.7. Asia Pacific Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Type of Diagnostic Radioisotope, 2021-2034 13.4.8. Asia Pacific Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Type of Therapeutic Radioisotope, 2021-2034 13.4.9. Asia Pacific Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034 13.4.10. Asia Pacific Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2021-2034 13.5. Latin America 13.5.1. Latin America Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034 13.5.1.1. Argentina 13.5.1.2. Brazil 13.5.1.3. Mexico 13.5.1.4. Rest of LATAM 13.5.2. Latin America Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2021-2034 13.5.3. Latin America Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Type of Isotope, 2021-2034 13.5.4. Latin America Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Radioisotope 2021-2034 13.5.5. Latin America Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Production Method, 2021-2034 13.5.6. Latin America Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2021-2034 13.5.7. Latin America Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Type of Diagnostic Radioisotope, 2021-2034 13.5.8. Latin America Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Type of Therapeutic Radioisotope, 2021-2034 13.5.9. Latin America Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034 13.5.10. Latin America Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2021-2034 13.6. Middle East & Africa 13.6.1. Middle East & Africa Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 13.6.1.1. Egypt 13.6.1.2. Israel 13.6.1.3. Nigeria 13.6.1.4. Saudi Arabia 13.6.1.5. Qatar 13.6.1.6. United Arab Emirates 13.6.1.7. Rest of MEA 13.6.2. Middle East & Africa Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2021-2034 13.6.3. Middle East & Africa Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Type of Isotope, 2021-2034 13.6.4. Middle East & Africa Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Radioisotope 2021-2034 13.6.5. Middle East & Africa Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Production Method, 2021-2034 13.6.6. Middle East & Africa Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2021-2034 13.6.7. Middle East & Africa Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Type of Diagnostic Radioisotope, 2021-2034 13.6.8. Middle East & Africa Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Type of Therapeutic Radioisotope, 2021-2034 13.6.9. Middle East & Africa Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034 13.6.10. Middle East & Africa Medical Isotope Production Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2021-2034 Chapter 14. Competitive Landscape 14.1. Major Mergers and Acquisitions/Strategic Alliances 14.2. Company Profiles 14.2.1. Actinium Pharmaceuticals 14.2.1.1. Business Overview 14.2.1.2. Key Product/Service 14.2.1.3. Financial Performance 14.2.1.4. Modeance 14.2.1.5. Geographical Presence 14.2.1.6. Recent Developments with Business Strategy 14.2.2. Fussion Pharmaceuticals 14.2.3. Jubilant Radiopharma 14.2.4. Lantheus 14.2.5. Kinectrics 14.2.6. Bayer 14.2.7. IRE 14.2.8. Novartis 14.2.9. Siemens Healthineers 14.2.10. NTP Radioisotopes 14.2.11. Taiyo Nippon Sanso 14.2.12. Telix 14.2.13. Other Prominent Players

量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們